Rahul A. Parikh, Ph.D.
Affiliations: | 2006 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Genetics, Oncology, Public HealthGoogle:
"Rahul Parikh"Cross-listing: GenetiTree
Parents
Sign in to add mentor| Susanne Gollin | grad student | 2006 | University of Pittsburgh (GenetiTree) | |
| (The DNA damage response pathway in oral squamous cell carcinoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Voss MH, Bhatt RS, Vogelzang NJ, et al. (2019) A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. Cancer |
| Achkar T, Ali SM, Welsh A, et al. (2018) A Prolonged Response to Platinum-Based Therapy in a Patient with Metastatic Urothelial Carcinoma Harboring a Single Rearranged and Truncated NF2 Gene. Genes, Chromosomes & Cancer |
| Appleman LJ, Logan TF, Normolle DP, et al. (2018) Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study. Journal of Clinical Oncology. 36: 106-106 |
| Roy S, Pradhan D, Ernst WL, et al. (2017) Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc |
| Mehta K, Patel K, Parikh RA. (2017) Immunotherapy in genitourinary malignancies. Journal of Hematology & Oncology. 10: 95 |
| Appleman LJ, Logan TF, Normolle DP, et al. (2017) Safety and preliminary activity of hydroxychloroquine and aldesleukin in metastatic renal cell carcinoma (mRCC): A cytokine working group study. Journal of Clinical Oncology. 35: 440-440 |
| Nguyen NC, Shah M, Appleman LJ, et al. (2016) Radium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case Presentation. International Journal of Molecular Imaging. 2016: 2568031 |
| Parikh RA, Appleman LJ, Beumer JH, et al. (2016) Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features. Clinical Genitourinary Cancer |
| Mehta K, Appleman L, Wang H, et al. (2016) Annual Hospital Volume of High Dose Interleukin-2 and Inpatient Mortality in Melanoma and Renal Cell Carcinoma Patients. Plos One. 11: e0147153 |
| Sakao K, Vyas AR, Chinni SR, et al. (2015) CXCR4 is a novel target of cancer chemopreventative isothiocyanates in prostate cancer cells. Cancer Prevention Research (Philadelphia, Pa.). 8: 365-74 |